Photo of Jerónimo Rafael Rodríguez Cid taken from medicasur.com.mx
Sep 6, 2024, 15:44
Jerónimo Rafael Rodríguez Cid: EGFR mutated patients doesnt have any benefit with immunotherapy in TKI’s resistant tumors
Jerónimo Rafael Rodríguez Cid, Medical Oncologist in CDMX, shared a post on X:
“We published in JCO by ASCO the analysis of this trial which reflects that EGFR mutated (lung cancer) patients doesn’t have any benefit of treatment with immunotherapy in TKI’s resistant tumors.
We will never stop trying.”
Source: Jerónimo Rafael Rodríguez Cid/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 14:15
May 29, 2025, 13:35
May 29, 2025, 13:11
May 29, 2025, 12:46
May 29, 2025, 12:43